Purpose To investigate whether the human LMTK2 and PARP-2 gene defects are associated with azoospermia by meiotic arrest, mutational analysis was performed on Japanese men with azoospermia. Methods Via direct sequencing, mutational screening was carried out on the exon region of the genes, using genomic DNAs from 18 Japanese men. Statistical analysis was done on the detected single nucleotide polymorphisms (SNPs) in the patients and normal controls. Results Nine SNPs were detected in LMTK2 and five SNPs were detected in PARP-2. There were no significant differences in the genotype distribution and allele frequencies between the two groups in LMTK2. However, the genotype frequency of heterozygotes in SNP1 of PARP-2 was higher in the patient group. The haplotype analysis revealed that SNP1-SNP4 (T-A) of PARP-2 was significantly more frequent in the patient group.
Introduction
Genetic causes of severe male infertility include chromosomal abnormalities, such as Y-chromosome microdeletions, and several specific gene mutations, such as those in AZF, DAZ, RBMY, USP9Y, and SYCP3 [1] [2] [3] [4] [5] . Genetic polymorphism may also be a factor in some forms of male infertility.
In spermatogenesis, there are two different events: meiosis (the major event) and postmeiotic differentiation. Aberrance of either event results in male infertility. To date, a number of genes responsible for azoospermia have been identified in the mouse; however, only a few have been identified in humans. The most common example of a meiotic defect is the aberrance of prophase I (comprising some complicated steps, such as paring, synapsis, and recombination). Proper synapsis requires a synaptonemal complex (SC) specific to meiosis. Abnormal SC component proteins and incomplete SC formation cause azoospermia in the mouse [6, 7] . Impairment of double-strand break (DSB) initiating recombination and DSB repair also cause meiotic arrest in spermatocytes [8] [9] [10] .
Several genes, which perform critical roles in postmeiotic differentiation of mouse spermatogenesis, have been reported [11, 12] . One of them is the mouse Brek/Lmtk2 (brain-enriched kinase/lemur tyrosine kinase 2) gene [13] . The Lmtk2 gene is expressed in other organs besides the testis, and is particularly high in the brain; Lmtk2 gene-deficient mice exhibit normal health except for azoospermia. Lmtk2 gene deficient female mice possess normal fertility; however, the males are infertile secondary to a defect of spermatid elongation and the germ cells differentiate normally until the round-spermatid stage. The Lmtk2 gene is essential for late stage-spermatogenesis in the mouse. The mouse poly(ADP-ribose) polymerase-2 (Parp-2) gene is known to perform an important role in DNA repair [14] . In addition, it has been demonstrated that Parp-2 gene deficient mice exhibit severely impaired spermatogenesis [15] . This gene performs essential functions during meiosis and haploid gamete differentiation in mouse spermatogenesis.
In this study, we performed mutational analysis of the human LMTK2 and PARP-2 genes on Japanese men with azoospermia secondary to meiotic arrest.
Materials and methods

Patients and controls
Idiopathic azoospermia was confirmed by two consecutive semen analyses obtained after 5 to 7 days of sexual abstinence and examination of a centrifuged semen pellet. Patients with defective spermatogenesis following infection, an obstruction of the seminal tract, pituitary failure, or other types of testicular damage were excluded from the study. All patients in this study underwent testicular sperm extraction (TESE) and sperm was absent in all specimens. Final diagnoses were carried out by histological examinations. Histological examinations were meticulously performed by several pathologists and urologists. Chromosome analysis of peripheral lymphocytes revealed a karyotype of 46, XY in all patients; thus, 18 Japanese men with azoospermia secondary to meiotic failure were included in the study. We have accumulated DNA samples from more than 5,000 patients with azoospermia; however, azoospermia caused by meiotic arrest is very rare and our diagnostic criteria were very strict. In general, pathological diagnosis is final diagnosis. However, there are sometimes some discrepancies between clinical diagnosis and pathological one when TESE was performed. As the important tissues judged by seeing with the naked eye are used for looking for sperm and the other parts are used for pathological diagnosis, it may be happened that there are sperm in testis but pathological diagnosis are meiotic arrest or sertoli cell only syndrome (SCOS). All of the analyzed patients in this study have no sperm even in their testis. Because of our strict criteria, the number of analyzed patients was only 18.
A LMTK2 gene analysis was conducted on 50 healthy, pregnancy-proven fertile controls; a PARP-2 gene analysis was conducted on 318 healthy, pregnancy-proven fertile controls. In addition, 86 patients with SCOS were also analyzed on the PARP-2 gene. All subjects were Japanese and gave written informed consent for molecular analysis of their blood. This study was approved by a local ethics committee.
Mutational screening
A total of 18 Japanese men diagnosed with azoospermia secondary to meiotic arrest were screened for mutations in the LMTK2 and PARP-2 genes. These full length cDNA sequences were compared to each human genomic sequences (NT_007933.14 and NT_026437.11), and all exonintron borders were determined. Nested or semi-nested PCRs were performed using primers with the intronic regions adjacent to each exon. Because of its large size, PCR was performed exclusively on exon 11 of the LMTK2 gene, using five separated primers sets. The primers listed below were used for mutational analysis. The sequences of oligonucleotide primers are presented in Tables 1 and 2. Exon 7: pE7F1, pE7F2, pE7R1 and pE7R2; Exon 8: pE8F1, pE8F2, pE8R1 and pE8R2; Exon 9: pE9F1, pE9F2, pE9R1 and pE9R2; Exon 10, Exon 11: pE11F1, pE11F2, pE11R1 and pE11R2; Exon 12, Exon 13: pE12F1, pE12F2, pE12R1 and pE12R2; Exon 14, Exon 15, Exon 16: pE14F1, pE14F2, pE14R1 and pE14R2;
Nested or semi-nested PCRs were performed using primers for each intronic region and 10-fold diluted first PCR products were used as templates. PCR was performed on a final volume of 25 μl, consisting of genomic DNA (10 ng), dNTP (0.32 mM each; TaKaRa, Shiga, Japan), each primer (0.2 μM), Taq polymerase (0.625 U; Roche, Tokyo, Japan), and a reaction buffer containing MgCl 2 (Roche). Nested and semi-nested PCRs were carried out for 20 cycles under the same conditions above but with 2 μl of Forward primer Reverse primer 10-fold diluted first PCR products as templates, using a programmable PC 960G gradient thermal cycler using a PCR system (Cosmo Bio, Tokyo, Japan) as follows: initial denaturation at 95°C for 150 s, followed by 32 cycles of denaturation at 95°C for 30 s, annealing (primers T m -5°C) for 90 s and extension at 72°C for 90 s. PCR products were purified using a QIAquick PCR Purification kit (Qiagen, Tokyo, Japan), and direct sequencing of each product was carried out. To confirm the role of the detected polymorphism in azoospermia, groups of 50, 150 and 318 healthy and fertile controls were also analyzed by direct sequencing analysis.
Genotyping and statistical analyses (single-locus analysis)
To investigate the role of LMTK2 and PARP-2 polymorphisms in azoospermia, 18 patients were compared to the genotype and allele frequencies found in the 50, 150, and 318 normal controls. In addition, 86 patients with SCOS were compared to the genotype and allele frequencies on the PARP-2. Fisher's exact test was used to determine significant differences. A P<0.05 was considered to be statistically significant. The Hardy-Weinberg equilibrium (HWE) was tested using SNPlyze software (DYNACOM, Chiba, Japan). Linkage disequilibrium (LD) of all possible two-way combinations of SNP with the absolute value of the correlation coefficient (D′) was tested.
P-values were determined via χ 2 approximation. Significance was determined with a P<0.05 as described above. Haplotype frequencies were estimated by the method of maximum likelihood based on the expectation-maximization (E-M) algorithm under the assumption of HWE. Linkage disequilibrium and haplotype frequencies were tested using SNPAlyze software (DYNACOM). P values were determined via χ 2 approximation; significance was determined at the P=0.05 level.
Results
Using direct sequence analysis of the LMTK2 gene of the 18 Japanese men, we identified nine single-nucleotidepolymorphisms (SNPs). The SNPs were: C381G (SNP1) in exon 1; T2371C, T2631A, G2726A, A2780T, C3164T, G3641A and A4145G (SNP2-8) in exon 11; and T5277C (SNP9) in exon 14. By comparing our results to the NCBI dbSNP database, four of nine SNPs (SNP2, SNP5, SNP6, and SNP9) were unique.
Genotyping for LMTK2 SNP alleles in the 18 patients and 50 control individuals revealed that there were no significant differences in the genotype distribution and the allele frequency in all SNPs (Table 3) . Minor allele frequencies ranged from 1.0% to 30.6%. Although there were CC, AA and GG homozygotes at the SNP2, SNP7
Forward primer Reverse primer Exon1 pE1F1=5′-cgtgagtctgttccaagctc-3′ pE1R1=5′-gctccgcaaggctttatgca-3′ pE1F2=5′-ccagaacacatagcgacatg-3′ pE1R2=5′-aggttatagggagctggaag-3′ Exon2 and 3 pE2F1=5′-cagatcacttgaggtcacga-3′ pE2R1=5′-ctaccactcctatctcttgc-3′ pE2F2=5′-cacgtattcgggtgtgtact-3′ pE2R2=5′-ctaacagcatcccagacagg-3′ Exon4 pE4F1=5′-aggttacacccaggttactg-3′ pE4R1=5′-tcctgagagatgaagtgaga-3′ pE4F2=5′-ccttgggagatgaatgttga-3′ pE4R2=5′-gatctgaacactgtgatgct-3′ Exon5 pE5F1=5′-accagctgctatgccttatc-3′ pE5R1=5′-cctgccattccccaatttca-3′ pE5F2=5′-caagtcaggtcaggttaggt-3′ pE5R2=5′-aaggctctcccagacttcag-3′ Exon6 pE6F1=5′-gagcagcccattgagtctga-3′ pE6R1=5′-cttagagaaggcagggcacg-3′ pE6F2=5′-ctttcctgcctgtttgtcag-3′ pE6R2=5′-caacatggcgaaaccccatc-3′ Exon7 pE7F1=5′-agctaggagtttgagaccag-3′ pE7R1=5′-ttgagcccaggaattcgaga-3′ pE7F2=5′-ggtgtttgggaaggacaagc-3′ pE7R2=5′-aggtgggaggatcacttgag-3′ Exon8 pE8F1=5′-ccaggatgctgaaactgtcc-3′ pE8R1=5′-ccacttcagcttcgcaagta-3′ pE8F2=5′-gctgtctttacacactgacg-3′ pE8R2=5′-ccatacaacctgtcacccca-3′ Exon9 pE9F1=5′-gccccacttggtaggacttc-3′ pE9R1=5′-gtcacggggctctataaagc-3′
pE9F2=5′-tggggtgacaggttgtatgg-3′ pE9R2=5′-tacttgggtggttggatagc-3′ Exon10 and 11 pE11F1=5′-ctttatagagccccgtgacc-3′ pE11R1=5′-tggcagacctttctgctccc-3′ pE11F2=5′-gtcatgcgccttttagccac-3′ pE11R2=5′-ctaggaaaagcttggccttc-3′ Exon12 and 13 pE12F1=5′-tgtttgggagcagaaaggtc-3′ pE12R1=5′-gcagtaattggcactcttgg-3′ pE12F2=5′-cagttcagctcagtctcttg-3′ pE12R2=5′-tgagctggcttaactcttgg-3′ Exon14,15 and 16 pE14F1=5′-gtgaggggaaatggagaagg-3′ pE14R1=5′-aggatgttgagtagtgggag-3′ pE14F2=5′-gtcagtggtatgcaccttct-3′ pE14R2=5′-ctttgttgcctctacccttc-3′ and SNP8 sites in the patient group, no homozygotes were found in the control group (0.056 vs. 0.000). However, there were no significant differences between the two groups. Hardy-Weinberg equilibrium of the distribution of genotypes for each SNP for the case group was evaluated by the χ 2 test; this test revealed that SNP1, SNP5, SNP6 and SNP9 of patients exhibited a significant deviation (P<0.05).
Pair-wise LD between SNPs was tested for all possible two-way comparisons; a strong LD was verified in four pair SNPs with a D′ value of 1.00 and a P value of <0.05 by the χ 2 test (both patient and control groups). The result of LD assessment of SNP2, SNP3, SNP4, SNP7 and SNP8 via Hardy-Weinberg equilibrium is summarized in Table 4 . SNP2, SNP7 and SNP8 as well as SNP3 and SNP4 sites were in complete LD.
Haplotype frequencies for various combinations were estimated via an expectation maximization algorithm. The results of combinations of two and three loci in HWE and in the strong LD are presented in Table 5 . Two haplotypes of those combinations (SNP2-SNP7-SNP8 and SNP3-SNP4 Fisher's exact test between patients and controls HWE Hardy-Weinberg equilibrium In these Japanese men, we identified five SNPs in the human PARP-2 as follows: C1159T (SNP1) in exon 11; G1359A (SNP2) in exon 13; A1469C (SNP3) in exon 14; and A1789C (SNP4) and T1790C (SNP5) in exon 16 . By comparing this result to the NCBI dbSNP database, all detected SNPs were unique. Although the major allele of SNP1 is T in the genomic sequence listed in NCBI database, in this study, the major allele of SNP 1 was C.
The genotype frequencies of heterozygotes in SNP1 and SNP2, as well as the minor allele frequency in SNP2, were higher in the patient group with significant differences (Table 6 ). However, the TT homozygote in SNP 1 was detected only in the control group; therefore, there were no significant differences in the minor allele frequencies of SNP1 between the patient and control group. There were no significant differences between the patient and control groups in regard to genotype and minor allele frequencies (Table 7 ). In analysis of haplotype frequencies, SNP1-SNP4 (T-A) haplotype was found to be significantly more frequent in the patient group than in the control group (Table 8) . The 86 patients with SCOS were also analyzed on SNP1 and SNP4 in the PARP-2. However, there are no statistically significant differences on the frequencies of genotypes, alleles and haplotypes between the patients with meiotic arrest and SCOS (p>0.05).
Discussion
Via mutational analysis of the LMTK2 gene, nine genetic variations could be found including the four unique SNPs. Exon 11 is the longest exon and almost all of the nine SNPs were identified in this region. Genotype and minor allele frequencies were found to have no significant differences between the patient and control groups. The reason that three were ruled out by HWE was probably due to the fact that the population was insufficient. The five SNPs (SNP2, SNP3, SNP4, SNP7, and SNP8) were in HWE. There is an amino acid substitution in SNP2 and SNP3; however, the others are synonymous. By LD analysis, SNP2 is in complete linkage disequilibrium with SNP7 and SNP8. In addition, SNP3 also has complete linkage disequilibrium with SNP4. Amino acid substitution is induced in both of these haplotypes; however, no statistically significant difference could be detected between the patient and control groups. The Lmtk2 -/-male mice are infertile due to azoospermia; however, differentiation normally takes place until the round-spermatid stage [13] . In the present study, we analyzed the patients with azoospermia secondary to early meiotic arrest; therefore, no differences might be found between the patient and control groups.
By mutational analysis of the PARP-2 gene, SNP2 and SNP3 of the five detected SNPs resulted in amino acid substitutions. In addition, both genotype and minor allele frequencies were significantly different between the patient and control groups only in SNP2. However, three SNPs (SNP2, SNP 3 and SNP5) were ruled out by HWE because of their P values. Therefore, we have to analyze more samples especially on the SNP2. Conversely, SNP1 and SNP4 are in HWE, and the SNP1-SNP4 (T-A) haplotype was higher with statistical significance in the patient group. SNP4 (A) was a major allele and SNP1 had no amino acid substitution.
Poly(ADP-ribosylation) is a post-translational modification of nuclear proteins in response to DNA damage [14] . PARPs contribute to the DNA repair and apoptosis by detection and signaling of the strand-break [15] . In addition, it was demonstrated that the Parp-2 gene play essential roles in both meiotic and postmeiotic processes in the mouse [16] . Parp-2 deficient mice exhibit severely impaired spermatogenesis, with a defect in prophase of meiosis I (characterized by massive apotosis at pachytene and metaphase I stages). In this study, we demonstrated that the genotype frequency of heterozygote of SNP1 and the haplotype frequency of SNP1-SNP4 were higher in the patient than the control groups. In addition, SNP2 of PARP-2 was found only in patient groups with significant differences. We believe that the patient group of 18 men is far too small for an association study. However, azoospermia by meiotic arrest is very rare and our histological diagnostic criteria are very strict. We have the DNA samples from more than 5,000 patients with azoospermia; however, only 18 patients had azoospermia secondary to meiotic arrest. In addition, we could not find a significant difference between the patients with meiotic arrest and SCOS.
Therefore, these results suggest that the human PARP-2 gene might also be associated with azoospermia caused by meiotic arrest.
In conclusion, this is the first report demonstrating that PARP-2 SNPs may predispose men to a defect in spermatogenesis; however, the mechanism whereby these SNPs result in azoospermia remains uncertain. Our results may also advance a better understanding of the molecular basis of meiotic arrest as a cause of non-obstructive azoospermia. The study of a larger sample and/or other ethnic groups is clearly indicated.
